Wealth Dimensions Group, Ltd. Bristol Myers Squibb CO Transaction History
Wealth Dimensions Group, Ltd.
- $484 Million
- Q3 2025
A detailed history of Wealth Dimensions Group, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Dimensions Group, Ltd. holds 8,781 shares of BMY stock, worth $409,458. This represents 0.08% of its overall portfolio holdings.
Number of Shares
8,781
Previous 9,432
6.9%
Holding current value
$409,458
Previous $436,000
9.17%
% of portfolio
0.08%
Previous 0.1%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,666Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA196MShares$9.14 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.42 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.1B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...